Tectonic Therapeutic Inc.
03/02/2026 | Press release | Distributed by Public on 03/02/2026 07:04
Tectonic Therapeutic to Participate in March Investor Conferences
WATERTOWN, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) ("Tectonic"), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that company management will participate in two upcoming investor conferences taking place in March 2026.
| TD Cowen 46th Annual Health Care Conference | |
| Date: | March 4, 2026 |
| Time: | 11:10 AM EST |
| Location: | Boston, MA |
| Format: | Fireside Chat |
| Presenters: | Alise Reicin, MD, President and Chief Executive Officer |
| Webcast: | Link |
|
Leerink Global Healthcare Conference |
|
|
Date: |
March 11, 2026 |
|
Time: |
1:40 PM EST |
|
Location: |
Miami, FL |
|
Format: |
Fireside Chat |
|
Presenters: |
Alise Reicin, MD, President and Chief Executive Officer |
|
Webcast: |
Link |
The live fireside chats can also be accessed under "Events & Presentations" on the Investors section of the Tectonic website at www.tectonictx.com. A replay of the webcasts will be available on the Company's website for approximately 90 days.
The Tectonic management team will host one-on-one meetings during the two conferences. Interested investors should contact their TD Cowen and Leerink representatives to schedule meetings.
About Tectonic
Tectonic Therapeutic is a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Leveraging its proprietary technology platform called GEODe™ (GPCRs Engineered for Optimal Discovery), Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. Tectonic focuses on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life. Tectonic is headquartered in Watertown, Massachusetts. For more information, please visit www.tectonictx.com and follow us on LinkedIn.
Contacts: Investors: Dan Ferry LifeSci Advisors (617) 430-7576 [email protected] Media: Kathryn Morris The Yates Network (914) 204-6412 [email protected]
Source: Tectonic Therapeutic
Tectonic Therapeutic Inc. published this content on March 02, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on March 02, 2026 at 13:04 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]